Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road aheadAlessandro Grattoni, Paul de Vos, Andrew R. Pepper et al.|Nature Reviews Endocrinology|2024Cited by 84
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysisPeter Taylor, Jan Dutz, Kimberly S. Collins et al.|The Lancet Diabetes & Endocrinology|2023Cited by 58